Wow! eBook
Special Issues in Pharmacovigilance in Resource-Limited Countries
Author(s): Syed Rizwanuddin Ahmad
- Publisher: Adis
- Publication Date: October 2, 2025
- Language: English
- Print length: 392 pages
- ISBN-10: 9819661536
- ISBN-13: 9789819661534
Book Description
Examining the state of pharmacovigilance systems in resource-limited countries, this book addresses the critical role that pharmacovigilance systems play, as drugs and vaccines become increasingly accessible in these settings. Issues unique to these countries are explored, including medical product safety and quality problems, the nature of support needed to build pharmacovigilance system capacity to effective level, global and regional strategies and efforts to develop institutional and professional capacity; the challenges being faced and how these are being tackled.
This book is a must-read resource for anyone involved in the provision of safe, and quality medical products; and its rational use in resource-limited settings, including staff of pharmacovigilance centers, regulatory authorities, academia, contract research organizations, the pharmaceutical industry, donor agencies and technical assistance providers.
This book is unique in its focus on pharmacovigilance in resource-limited countries (RLCs). Many RLCs face serious challenges in maintaining health care systems, ensuring access to essential medicines and promoting drug safety. The editor has built an exceptional and well-balanced pharmacovigilance compendium. The individual chapters by experts provide a valuable resource of national and regional pharmacovigilance experiences. A very good read not only for pharmacovigilance professionals in RLCs, but also for donors and other international organisations.
Hubert G Leufkens, PhD, FISPE, Professor of Pharmaceutical Policy
and Regulatory Science, Utrecht Institute for Pharmaceutical Sciences (UIPS),
Former Head of the Dutch regulatory agency (MEB), The Netherlands
I foresee this collection will become a very useful reference for everyone working or supporting the development of pharmacovigilance in countries with limited resources. We have utilized the services of Dr. Ahmad on several occasions. His passion and focus on important issues resonates throughout the book.
Adel Al-Harf, PhD, Vice President of the Drug Sector,
Saudi Food and Drug Authority (SFDA), Kingdom of Saudi Arabia
Editorial Reviews
From the Back Cover
Medical products have dramatically revolutionized how diseases are treated or prevented. At the same time, inappropriate use of these products is associated with increased incidence of adverse reactions. This problem is acute in resource-limited countries in the absence of adequate monitoring systems. This book examines and highlights the critical role and need for pharmacovigilance systems in these settings.
Issues unique to these countries are explored, including medical product safety and quality problems; the nature of support needed to build pharmacovigilance system capacity to effective levels; global and regional strategies and efforts to develop institutional and professional capacity; the challenges being faced and how these are being tackled.
This book is a must-read resource for anyone involved in the provision of safe, and quality medical products; and its rational use.
“This book is unique in its focus on pharmacovigilance in resource-limited countries.”
Hubert G Leufkens, PhD, FISPE, Professor of Pharmaceutical Policy and Regulatory Science, Utrecht Institute for Pharmaceutical Sciences (UIPS),
Former Head of the Dutch regulatory agency (MEB), The Netherlands
“I foresee this collection will become a very useful reference for everyone working or supporting the development of pharmacovigilance in countries with limited resources.”
Adel Al-Harf, Ph.D., Vice President of the Drug Sector, Saudi Food and Drug Authority (SFDA), Kingdom of Saudi Arabia
Dr. Ahmad is a drug safety consultant who served the U.S. FDA for 15 years. He received his medical degree from Dow Medical College, Karachi; public health degree from Johns Hopkins, Baltimore, and did clinical pharmacology fellowship at Georgetown University, Washington, DC.
Dr. Ahmad has a passion to train regulators and help establish pharmacovigilance centres. He has conducted pharmacovigilance training in Eswatini, Cambodia, Kuwait, Laos, Oman, the Philippines, Pakistan, Palestine, Saudi Arabia, and the UAE.
Dr. Ahmad has contributed chapters on pharmacovigilance, and the FDA approval process in seven texts including the past editions of Brian Strom’s ‘Textbook of Pharmacoepidemiology’ and Ronald Mann’s ‘Pharmacovigilance’.
About the Author
Dr. Ahmad is a drug safety consultant who served the U.S. FDA for 15 years. He received his medical degree from Dow Medical College, Karachi; public health degree from Johns Hopkins, Baltimore, and did clinical pharmacology fellowship at Georgetown University, Washington, DC.
Dr. Ahmad has a passion for teaching pharmacovigilance. He has conducted training in Eswatini, Cambodia, Kuwait, Laos, Oman, the Philippines, Pakistan, Palestine, Saudi Arabia, and the UAE.
He has contributed chapters in pharmacovigilance and the FDA approval process in seven textbooks including the past editions of Brian Strom’s textbook on ‘Pharmacoepidemiology’ and Ron Mann’s textbook on ‘Pharmacovigilance’.
